explore -WSS

explore

author：Wikipedia 2025-09-28 15:21:02 - browse：2861

Adam's take main illustration — Molly Ferguson/STAT

Shares of Apellis Pharmaceuticals are rebounding, driven by a growing belief among some investors that the serious safety issue that has derailed Syfovre, the company’s eye disease treatment, is receding.

Declaring the crisis over is premature, but that could change with more uneventful weeks. Apellis has been a takeout target before, and may be again, at an acquisition price nearly twice its current market value.

Apellis shares rose 32% last week, with most of the gains coming Friday on heavy trading volume. The reason: There have been no new cases of retinal occlusive vasculitis, or ROV, reported in people receiving injections of Syfovre.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： H5N1 virus can be tracked in retail milk, scientists say

entertainment

leisure time

WSS

Diversifying clinical trials isn't enough to close racial gaps: study

At flashy new research hub, AstraZeneca lays out ambitious growth goals

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

Biogen joins immunology wave with $1.15 billion acquisition of HI

Readout Newsletter: XBI biotech index, Akero Therapeutics

Citing H5N1 threat, CDC urges peak flu monitoring this summer

hotspot

explore

focus

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

H5N1 virus can be tracked in retail milk, scientists say

Jerome Adams on the need for new antivirals for Covid

Listen: A conversation with researcher Kevin Esvelt on biosecurity

As demand for Covid shots wanes, Moderna seeks its next success

Addressing health care workers' trauma can help fight burnout

What does generative AI mean for health care? We asked experts

Telehealth options flood the market as retailers push virtual care

ChatGPT in medicine: STAT answers readers' burning questions

Addressing health care workers' trauma can help fight burnout

focus

Study finds gene variants tied to breast cancer risk in Black women

Questions and answers about ramping up H5N1 bird flu vaccine

First Opinion Podcast: How to protect health care in times of war

H5N1 bird flu outbreak: Second human case reported, in Michigan

Scrutiny of post

Medtronic CEO on promising devices for diabetes, hypertension

knowledge

entertainment

leisure time

leisure time